S E Salmon
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 14
- Cancer Cells and Metastasis 9
- Drug Transport and Resistance Mechanisms 2
-
- Multiple Myeloma Research and Treatments 7
- Co-authors
- Alberts Ds (8 shared papers)Barbara J. Soehnlen (6 shared papers)Hamburger Aw (5 shared papers)Frank L. Meyskens (5 shared papers)JM Trent (1 shared paper)Von Hoff (2 shared papers)S E Jones (3 shared papers)Albert Schilling (1 shared paper)
- Journals
- PubMed (34 papers)
- Partner nations
- United States
In The Last Decade
S E Salmon
34 papers receiving 881 citations
Peers
Comparison fields: 5 of 72
- Oncology 401
- Hematology 235
- Toxicology 53
- Reproductive Medicine 95
- Cancer Research 51
Countries citing papers authored by S E Salmon
This map shows the geographic impact of S E Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Salmon more than expected).
Fields of papers citing papers by S E Salmon
This network shows the impact of papers produced by S E Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Salmon. The network helps show where S E Salmon may publish in the future.
Co-authors
The 23 scholars most cited alongside S E Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Direct cloning of human ovarian carcinoma cells in agar. | 1978 | 275 |
| 2 | Immunoglobulin synthesis and tumor kinetics of multiple myeloma. | 1973 | 129 |
| 3 | Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. | 1982 | 89 |
| 4 | New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay. | 1981 | 72 |
| 5 | Clinical correlations of in vitro drug sensitivity. | 1980 | 59 |
| 6 | In vitro evaluation of anticancer drugs with the human tumor stem cell assay. | 1981 | 47 |
| 7 | Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma. | 1967 | 43 |
| 8 | In vitro drug assay: pharmacologic considerations. | 1980 | 43 |
| 9 | Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial. | 1976 | 37 |
| 10 | In vitro clonal assay for human metastatic melanoma cells. | 1981 | 37 |
| 11 | Adriamycin (NSC-123127) in the treatment of alkylator-resistant multiple myeloma: a pilot study. | 1975 | 36 |
| 12 | Use of an image analysis system to count colonies in stem cell assays of human tumors. | 1980 | 35 |
| 13 | Nitrosoureas in multiple myeloma. | 1976 | 28 |
| 14 | Relevance of multidrug resistance to rheumatoid arthritis: development of a new therapeutic hypothesis. | 1996 | 27 |
| 15 | Development of a bioassay for human myeloma colony-forming cells. | 1980 | 17 |
| 16 | Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. | 1980 | 17 |
| 17 | A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion. | 1988 | 13 |
| 18 | Morphologic studies of tumor colonies. | 1980 | 12 |
| 19 | Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung. | 1977 | 11 |
| 20 | Hemopoietic stem cell transplants for multiple myeloma. | 1994 | 11 |
About S E Salmon
S E Salmon is a scholar working on Oncology, Hematology, Reproductive Medicine, Biophysics and Cancer Research, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (9 papers), Multiple Myeloma Research and Treatments (7 papers), Ovarian cancer diagnosis and treatment (3 papers), Cell Image Analysis Techniques (2 papers), Breast Cancer Treatment Studies (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Analytical Methods in Pharmaceuticals (1 paper) and Protein purification and stability (1 paper). The work is most often cited by research in Oncology (401 citations), Hematology (235 citations), Toxicology (53 citations), Reproductive Medicine (95 citations) and Cancer Research (51 citations). S E Salmon has collaborated with scholars based in United States. Frequent co-authors include Alberts Ds, Barbara J. Soehnlen, Hamburger Aw, Frank L. Meyskens, JM Trent, Von Hoff, S E Jones, Albert Schilling, Dalton Ws and Richard K. Shadduck. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.